ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 281817 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 281817; 2) Community: the network communities that were significantly associated with the response to NSC 281817; 3) Molecule: the relationships between components within communities and NSC 281817; 4) MDR: the compounds that were significantly associated with the NSC 281817.

NSC Compound Enrichment Correlation
NSC 737757 2-(4-((oxiran-2-yl)methoxy)styryl)-4,5-dihydrooxazole 0.0228801759885691 0.045174647
NSC 758119 (1R,6S,11aS,13S,14aR)-1,13-dihydroxy-6-vinyl-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f]oxacyclotridecin-4-one 0.0228801759885691 -0.36000113
NSC 227279 1,4-Naphthalenedione, 5,8-dihydroxy-2,3-bis(hydroxymethyl)- 0.0238174255956144 0.11257287
NSC 342610 Null 0.0238174255956146 0.54998679
NSC 626162 Discorhabdin C . TFA 0.0238174255956146 0.0076970206
NSC 644651 Null 0.0238174255956146 -0.033269804
NSC 658143 2-(1-(4-(2-(2-Hydroxyethoxy)ethyl)piperazino))naphthazarin 0.0238174255956146 -0.043611021
NSC 665771 Null 0.0238174255956146 0.22119711
NSC 700087 Bisoxireno[1,10a:3,4]phenanthro[3,2-b]furan-9(7aH)-one, 1,2, 3,4,4a,5,6,11a,11b,11c-decahydro-4,4,8,11c-tetramethyl-, [4aR-(4a.alpha.,6aS*,7a.beta.,10aR*,11a.beta.,11b.alpha.,11c.beta,)]- (9CI) 0.0238174255956146 -0.26685228
NSC 339705 5H-Indeno[1,2-c]isoquinoline-5,11(6H)-dione, 6-(2-hydroxyethyl)- 0.0241085022307781 0.48903301
Total:66  Current:31    [First] [Prev] [Next] [Last]